{"url_path":"/fda/drug/recalls/D-0787-2026","section_key":"summary","section_title":"DRUG Recall: Baxter Healthcare Corporation — Cefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-07-24","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0787-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Baxter Healthcare Corporation"},"word_count":80,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0787-2026\n\n**Recalling firm:** Baxter Healthcare Corporation\n**Classification:** Class I\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-07-24\n**Report date:** 2026-08-19\n\n## Product\nCefazolin in Dextrose, Injection, USP, 2g / 100mL (20mg / mL) Single-Dose Infusion Bag in 100mL GALAXY Plastic Container, Frozen Premix, Sterile, Rx only, Manufactured by Baxter Healthcare Corporation, Deerfield, IL 60015, USA, NDC 0338-3508-41.\n\n## Reason\nPresence of Particulate Matter\n\n## Affected lots\nLot # LD175708, Exp Date: 14-Feb-2027.\n\n## Distribution\nUS Nationwide."}